Fabien Lux is currently the Director and RSVt Drug Substance Leader at Sanofi's EVolutive Facility within MSAT. Previously, Fabien held various roles in prominent companies such as Aventis, METABOLIC EXPLORER, and Merial, focusing on bacterial and downstream process development, team management, and project management. Notable achievements include leading teams in developing industrial-scale fermentation processes and promoting technological innovation. With extensive expertise in fermentation and bioprocess development, Fabien has made significant contributions to the fields of vaccine production and microbial fermentation technologies.
This person is not in the org chart
This person is not in any teams
This person is not in any offices